Cargando…
Inhibition of the PCR by genomic DNA
AIMS: qPCR, is widely used for quantifying minimal residual disease (MRD) and is conventionally performed according to guidelines proposed by the EuroMRD consortium. However it often fails when quantifying MRD levels below 10(−4). By contrast, HAT-PCR, a recent modification designed to minimise fals...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120932/ https://www.ncbi.nlm.nih.gov/pubmed/37083935 http://dx.doi.org/10.1371/journal.pone.0284538 |